⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11799 | 1.00 | — | — | |
| SCHEMBL441286 | 1.00 | — | — | |
| Ethane SCHEMBL27625986 | 0.96 | TSHR (0.41) | — | |
| Methyl Alcohol SCHEMBL27464623 | 0.96 | TSHR (0.41) | — | |
| SCHEMBL2612208 | 0.90 | TSHR (0.37) | — | |
| Propane SCHEMBL28218331 | 0.90 | SHBG (0.46) | — | |
| SCHEMBL16248250 | 0.90 | TSHR (0.37) | — | |
| SCHEMBL14318801 | 0.90 | TSHR (0.37) | — | |
| SCHEMBL1006983 | 0.87 | — | — | |
| SCHEMBL4847697 | 0.87 | TSHR (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102477014-B | The preparation method of Peremin | SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. (CN) | 2015-08-19 | — | — | CN | claimed |
| CN-102477014-A | Preparation method of histamine dihydrochloride | SHANGDONG NEW TIME PHARM PROD | 2012-05-30 | — | — | CN | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| CN-121990874-A | Method for preparing trans-4-methylcyclohexanol with high selectivity | 郑州大学 | 2026-05-08 | — | — | CN | disclosed |
| CN-121990874-A | Method for preparing trans-4-methylcyclohexanol with high selectivity | 郑州大学 | 2026-05-08 | — | — | CN | disclosed |
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-04-23 | — | — | US | disclosed |
| CN-115175735-B | Antiviral compounds | 吉利德科学公司 | 2025-03-04 | — | — | CN | disclosed |
| EP-4486747-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2025-01-08 | — | — | EP | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| CN-118900839-A | Antiviral compounds and methods of making and using the same | 吉利德科学公司 | 2024-11-05 | — | — | CN | disclosed |
| EP-3365334-B1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMA CO LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-0215800-A1 | PYRIMIDINES. | MERCK PATENT GMBH (DE) | 1987-04-01 | — | — | EP | disclosed |
| EP-0210815-A2 | 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use | BEECHAM GROUP PLC (GB) | 1987-02-04 | — | — | EP | disclosed |
| EP-0202514-A2 | Liquid crystal esters | Chisso Corporation (JP) | 1986-11-26 | — | — | EP | disclosed |
| WO-1986004060-A1 | PYRIMIDINES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-07-17 | — | — | WO | disclosed |
| US-4490278-A | Liquid crystal substituted trans-4-n-alkylcyclohexanes and subst.-3-subst.-benzoyloxy-[trans-4-n-alkylcyclohexane]s | VEB WERK FUR FERNSEHELEKTRONIK IM VEB KOMBINAT MIKROELEKTRONIK (DE) | 1984-12-25 | — | — | US | disclosed |
| US-4489003-A | ANTICONVULSANTS, TRANQUILLIZERS | HOFFMANN-LA ROCHE INC. (US) | 1984-12-18 | — | — | US | disclosed |
| EP-0100906-A2 | Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-02-22 | — | — | EP | disclosed |
| US-4393228-A | THIOL PROTEASE INHIBITORS, ANTIINFLAMMATORY | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1983-07-12 | — | — | US | disclosed |
| US-4290961-A | Process for catalytically reducing carbonyl compounds | MONTEDISON S.P.A. (IT) | 1981-09-22 | — | — | US | disclosed |